Wei Lou
Impact in
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Prostate Cancer Treatment and Research
Papers in
-
- Prostate Cancer Treatment and Research 37
-
- Ubiquitin and proteasome pathways 6
- Co-authors
- Allen C. Gao (75 shared papers)Nagalakshmi Nadiminty (30 shared papers)Christopher P. Evans (37 shared papers)Chengfei Liu (38 shared papers)Yezi Zhu (15 shared papers)Soo Ok Lee (11 shared papers)Ramakumar Tummala (12 shared papers)Cameron M. Armstrong (22 shared papers)
- Journals
- The Prostate (15 papers)Molecular Cancer Therapeutics (14 papers)The Journal of Urology (11 papers)Cancer Research (10 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United StatesChinaBelgium
In The Last Decade
Wei Lou
94 papers receiving 4.3k citations
Wei Lou's Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 1.7k
- Oncology 1.0k
- Molecular Biology 1.9k
- Endocrinology, Diabetes and Metabolism 356
Countries citing papers authored by Wei Lou
This map shows the geographic impact of Wei Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lou more than expected).
Fields of papers citing papers by Wei Lou
This network shows the impact of papers produced by Wei Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lou. The network helps show where Wei Lou may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Lou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer Hit paper breakdown → | 2014 | 296 |
| 2 | 2000 | 237 | |
| 3 | 2015 | 201 | |
| 4 | 2011 | 161 | |
| 5 | Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells. | 2003 | 158 |
| 6 | 2013 | 156 | |
| 7 | 2012 | 147 | |
| 8 | 2002 | 120 | |
| 9 | 2006 | 118 | |
| 10 | 2013 | 105 | |
| 11 | 2015 | 101 | |
| 12 | 2022 | 101 | |
| 13 | 2016 | 99 | |
| 14 | 2013 | 92 | |
| 15 | 2010 | 92 | |
| 16 | 2017 | 90 | |
| 17 | 2018 | 89 | |
| 18 | 2009 | 88 | |
| 19 | 2016 | 86 | |
| 20 | 2015 | 86 |
About Wei Lou
Wei Lou is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Genetics, having authored 96 papers that have together received 4.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (37 papers), Cytokine Signaling Pathways and Interactions (8 papers), Estrogen and related hormone effects (7 papers), Cancer, Lipids, and Metabolism (7 papers), PARP inhibition in cancer therapy (7 papers), NF-κB Signaling Pathways (7 papers), Ubiquitin and proteasome pathways (6 papers) and Aldose Reductase and Taurine (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Pulmonary and Respiratory Medicine (1.7k citations), Oncology (1.0k citations), Molecular Biology (1.9k citations) and Endocrinology, Diabetes and Metabolism (356 citations). Wei Lou has collaborated with scholars based in United States, China and Belgium. Frequent co-authors include Allen C. Gao, Nagalakshmi Nadiminty, Christopher P. Evans, Chengfei Liu, Yezi Zhu, Soo Ok Lee, Ramakumar Tummala, Cameron M. Armstrong, Joy C. Yang and Zuyao Ni. Their work appears in journals such as The Prostate, Molecular Cancer Therapeutics, The Journal of Urology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.